Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 6Breast Neoplasms 3Pancreatic Neoplasms 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 2Psychiatric Rehabilitation 2Paclitaxel 2Early Intervention, Educational 2sargramostim 1regorafenib 1pentetreotide 1pembrolizumab 1pazopanib 1imetelstat 1glutathione pegylated liposomal doxorubicin 1durvalumab 1carboxyamido-triazole 1cabozantinib 1binimetinib 1aflibercept 1Trastuzumab 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Positron-Emission Tomography 1Pemetrexed 1Patient Reported Outcome Measures 1PF-07284890 1Oxycodone 1Nivolumab 1NEO212 1Morphine 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × pazopanib × Dermatologic × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡